An international research team has developed a new therapy based on nanotechnology called nanoGLA for the treatment of Fabry ...

Galafold (migalastat) is an oral precision medicine for adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant, based on in vitro assay data.

Amicus Therapeutics (NASDAQ:FOLD – Get Free Report)‘s stock had its “equal weight” rating reissued by Morgan Stanley in a ...

XTX Topco Ltd acquired a new stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) in the third quarter, ...